FindTrial
Sign In

To Evaluate The Efficacy Of Hriberadi Paneeya(A Classical Ayurvedic Formulation) In Dengue Fever

An Open-Label Clinical Trial To Evaluate The Efficacy Of Hriberadi Paneeya (A Classical Ayurvedic Formulation) As Adjuvant Therapy In Management Of Dengue Fever - Nil

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/076100
Enrollment
80
Registered
2024-10-30
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 3- Administration

Interventions

None listed

Sponsors

Dr Veena Jigalur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: History of acute onset of fever 24 hrs to 48 hrs, Patients with Dengue NS1 positive Dengue IgM positive and Dengue IgM weekly Positive

Exclusion criteria

Exclusion criteria: 1) Patients with Dengue IgM positive(Treated on OPD basis) 2) Mentally retarded patients 3) Patients below 8Years and above 18 years of age 4) All chronic fevers of more than 21 days 5) patient entering shock will be excluded(dropped) 6)Patients with platelet count below 20000 will be excluded(dropped)

Design outcomes

Primary

MeasureTime frame
Dengue patients with Hriberadi Paneeya recover fastTimepoint: 7 days—

Secondary

MeasureTime frame
Dengue patients with Hriberadi Paneeya will not have recrudescenceTimepoint: 14 days;Dengue patients with Hriberadi Paneeya will not progress to complicationsTimepoint: 7 days—

Countries

India

Contacts

Public ContactDr Yogesh Deole

Charutar Vidya Mandal University Anand Gujarat

yogesh.deole@cvmu.edu.in9974999309

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026